{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:13:38Z","timestamp":1741238018132,"version":"3.38.0"},"reference-count":57,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"unspecified","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Prim Health Care Res Dev"],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:title>Abstract<\/jats:title>\n\t  <jats:sec id=\"S1463423625000155_as1\">\n\t    <jats:title>Objectives:<\/jats:title>\n\t    <jats:p>To analyze the sociodemographic characteristics and trends in clinical and analytical parameters among individuals with chronic kidney disease (CKD) in Aragon (Spain), who remain uninfected with COVID-19 during the first year of pandemic. The secondary objectives were to identify the associated comorbidities and their evolution throughout the pandemic, as well as to determine the cases that got worse and their possible relationship with the control of the main risk factors.<\/jats:p>\n\t  <\/jats:sec>\n\t  <jats:sec id=\"S1463423625000155_as2\">\n\t    <jats:title>Background:<\/jats:title>\n\t    <jats:p>CKD is a major public health problem worldwide. Studies encompassing national, European, and global contexts, show a rise in the prevalence of CKD, with a significant decrease in life quality, high morbidity and mortality, and increased healthcare costs. In this scenario, primary care is a cornerstone for the early detection of CKD and for the management of progression factors. To date, there are few publications regarding the evolution of the CKD population throughout the pandemic that are not related to hospitalizations or complications due to COVID-19.<\/jats:p>\n\t  <\/jats:sec>\n\t  <jats:sec id=\"S1463423625000155_as3\">\n\t    <jats:title>Methods:<\/jats:title>\n\t    <jats:p>We conducted a retrospective longitudinal study with real-world data from the population over 16 years of age registered in Aragon (Spain), collecting data from electronic health records. The variables included were sociodemographic, analytical and clinical (glomerular filtration rate, cholesterol, triglycerides, glycated haemoglobin, and blood pressure) and comorbidities (hypertension, dyslipidemia, obesity, diabetes, and smoking). The data were archived and processed using the SPSS v22.0 software package.<\/jats:p>\n\t  <\/jats:sec>\n\t  <jats:sec id=\"S1463423625000155_as4\">\n\t    <jats:title>Results:<\/jats:title>\n\t    <jats:p>During the first six months of COVID-19 pandemic, the clinical parameters of people with CKD were poorly controlled, although there was a later improvement which could be related to the progressive recovery of health services. The glycated haemoglobin value found was low, which makes us suspect possible overtreatment. There is a high prevalence of high blood pressure, diabetes, dyslipidemia, obesity and smoking. Interventions targeting these factors could help reduce the burden of CKD.<\/jats:p>\n\t  <\/jats:sec>","DOI":"10.1017\/s1463423625000155","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T10:25:57Z","timestamp":1741170357000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":0,"title":["Evolution of the population with chronic kidney disease in Spain in the context of the COVID-19 pandemic: a longitudinal retrospective study"],"prefix":"10.1017","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2448-1271","authenticated-orcid":false,"given":"Liliana","family":"Bilbie-Lupchian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6565-9699","authenticated-orcid":false,"given":"B\u00e1rbara","family":"Oliv\u00e1n-Bl\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4497-3341","authenticated-orcid":false,"given":"Beatriz","family":"Gonz\u00e1lez-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6333-7116","authenticated-orcid":false,"given":"Priscila","family":"Matovelle-Ochoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7980-1374","authenticated-orcid":false,"given":"Ver\u00f3nica","family":"Casado-Vicente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6982-839X","authenticated-orcid":false,"given":"Mar\u00eda Antonia","family":"S\u00e1nchez-Calavera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"S1463423625000155_ref12","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000058"},{"key":"S1463423625000155_ref48","first-page":"119","article-title":"Envejecimiento y funci\u00f3n renal. Mecanismos de predicci\u00f3n y progresi\u00f3n","volume":"2","author":"Otero","year":"2011","journal-title":"Nefrolog\u00eda Suplemento Extraordinario"},{"key":"S1463423625000155_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2021.07.010"},{"key":"S1463423625000155_ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.kisu.2021.01.007"},{"key":"S1463423625000155_ref53","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-14-46"},{"key":"S1463423625000155_ref39","first-page":"309","article-title":"Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new chronic kidney disease-epidemiology collaboration group formula","volume":"5","author":"McAlister","year":"2012","journal-title":"Circulation: Heart Failure"},{"key":"S1463423625000155_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60439-0"},{"key":"S1463423625000155_ref60","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy339"},{"key":"S1463423625000155_ref58","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32064-5"},{"key":"S1463423625000155_ref36","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz455"},{"key":"S1463423625000155_ref4","doi-asserted-by":"publisher","DOI":"10.1080\/09674845.2012.12069133"},{"key":"S1463423625000155_ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.02.022"},{"key":"S1463423625000155_ref30","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.12.012"},{"key":"S1463423625000155_ref46","unstructured":"NICE Guidelines (2014) Chronic kidney disease in adults: assessment and management; [Internet]. Available at https:\/\/www.nice.org.uk\/guidance\/cg182 (Accessed 10 August 2023)."},{"key":"S1463423625000155_ref1","first-page":"41","article-title":"Enfermedad renal cr\u00f3nica y coraz\u00f3n. Un continuo evolutivo","volume":"61","author":"Bardaj\u00ed","year":"2008","journal-title":"Revista Espanola de Cardiologia"},{"key":"S1463423625000155_ref55","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001794"},{"key":"S1463423625000155_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2018.04.004"},{"key":"S1463423625000155_ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2016.01.016"},{"key":"S1463423625000155_ref34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.medcle.2020.03.011","article-title":"Prevalence of chronic kidney disease and associated factors in the Spanish population attended in primary care: results of the IBERICAN study","volume":"156","author":"Llisterri","year":"2021","journal-title":"Medicina Clinica (English Edition)"},{"key":"S1463423625000155_ref26","first-page":"5","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney International Supplements"},{"key":"S1463423625000155_ref40","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000070147.10399.9E"},{"key":"S1463423625000155_ref21","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.200"},{"key":"S1463423625000155_ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2021.03.006"},{"key":"S1463423625000155_ref44","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V112319"},{"key":"S1463423625000155_ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30045-3"},{"key":"S1463423625000155_ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.06.019"},{"key":"S1463423625000155_ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100438"},{"key":"S1463423625000155_ref19","first-page":"1442","article-title":"Predecir el momento de los resultados cl\u00ednicos en pacientes con enfermedad renal cr\u00f3nica y tasa de filtraci\u00f3n glomerular gravemente disminuida","volume":"93","author":"Grams","year":"2018","journal-title":"Ri\u00f1\u00f3n internacional"},{"key":"S1463423625000155_ref38","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2216020"},{"key":"S1463423625000155_ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-1064-1"},{"key":"S1463423625000155_ref37","first-page":"243","article-title":"Documento de consenso para la detecci\u00f3n y manejo de la enfermedad renal cr\u00f3nica","volume":"34","author":"Mart\u00ednez-Castelao","year":"2014","journal-title":"Nefrolog\u00eda"},{"key":"S1463423625000155_ref8","doi-asserted-by":"publisher","DOI":"10.1089\/met.2011.0056"},{"key":"S1463423625000155_ref47","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000114519.75433.DD"},{"key":"S1463423625000155_ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"S1463423625000155_ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.11.006"},{"key":"S1463423625000155_ref61","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2015-000154"},{"key":"S1463423625000155_ref10","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.11.1130"},{"key":"S1463423625000155_ref23","first-page":"S69","article-title":"Blood pressure and risk of end-stage renal disease in a screened cohort","volume":"55","author":"Iseki","year":"1996","journal-title":"Kidney International Supplement"},{"key":"S1463423625000155_ref3","unstructured":"Centers for Disease Control and Prevention (2021) People with certain medical conditions. Updated March 29, 2021. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/people-with-medical-conditions.html"},{"key":"S1463423625000155_ref22","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6923e1"},{"key":"S1463423625000155_ref7","first-page":"38","article-title":"Comportamiento del perfil lip\u00eddico en pacientes con enfermedad renal cr\u00f3nica en estadios 2 a 4: Hospital central de Maracay, estado Aragua. A\u00f1o 2012","volume":"11","author":"Correa","year":"2013","journal-title":"Comunidad y Salud [online]"},{"key":"S1463423625000155_ref62","first-page":"113","article-title":"Terap\u00e9utica hipolipemiante en pacientes con enfermedad renal cr\u00f3nica","volume":"24","author":"Fern\u00e1ndez Vega","year":"2004","journal-title":"Nefrolog\u00eda"},{"key":"S1463423625000155_ref5","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2369-13-87"},{"key":"S1463423625000155_ref24","first-page":"1790","article-title":"Aceleraci\u00f3n del deterioro de la funci\u00f3n renal despu\u00e9s de una hospitalizaci\u00f3n incidente por enfermedad cardiovascular: el proyecto Estocolmo CREAtinine Measurements (SCREAM)","volume":"22","author":"Ishigami","year":"2020","journal-title":"Revista europea de insuficiencia card\u00edaca"},{"key":"S1463423625000155_ref32","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-019-0191-y"},{"key":"S1463423625000155_ref31","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006101159"},{"key":"S1463423625000155_ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.recesp.2011.05.019"},{"key":"S1463423625000155_ref20","first-page":"25","article-title":"La Hiperlipidemia como factor patog\u00e9nico en la insuficiencia renal progresiva","volume":"18","author":"Guijarro","year":"1998","journal-title":"Nefrolog\u00eda"},{"key":"S1463423625000155_ref6","first-page":"1","article-title":"Prevalencia de enfermedad renal cr\u00f3nica y disminuci\u00f3n de la funci\u00f3n renal en la poblaci\u00f3n adulta de EE. UU.: Tercera Encuesta Nacional de Examen de Salud y Nutrici\u00f3n","volume":"41","author":"Coresh","year":"2003","journal-title":"Revista americana de enfermedades renales"},{"key":"S1463423625000155_ref45","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.27369"},{"key":"S1463423625000155_ref14","doi-asserted-by":"publisher","DOI":"10.4321\/S2254-28842017000100002"},{"key":"S1463423625000155_ref2","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1581"},{"key":"S1463423625000155_ref18","unstructured":"Government of Spain, Ministry of the Presidency (2020) Royal Decree 463\/2020. Official State Gazette. 25390\u201325400. Available at https:\/\/www.boe.es\/boe\/dias\/2020\/03\/14\/pdfs\/BOE-A-2020-3692.pdf (Accessed 19 February 2023)."},{"key":"S1463423625000155_ref42","article-title":"The impact of the COVID-19 pandemic on outpatient visits: a rebound emerges","author":"Mehrotra","year":"2020","journal-title":"Commonwealth Fund"},{"key":"S1463423625000155_ref33","first-page":"1","article-title":"Enfermedad renal: mejora de los resultados globales (KDIGO) Grupo de trabajo sobre ERC. Gu\u00eda de pr\u00e1ctica cl\u00ednica KDIGO 2012 para la evaluaci\u00f3n y tratamiento de la enfermedad renal cr\u00f3nica","volume":"3","author":"Levin","year":"2013","journal-title":"Suplementos de Kidney International"},{"key":"S1463423625000155_ref35","volume-title":"Mathematical Psychology","author":"Lubin Pigouche","year":"2005"},{"key":"S1463423625000155_ref41","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp12X636047"}],"container-title":["Primary Health Care Research &amp; Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1463423625000155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T10:26:05Z","timestamp":1741170365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1463423625000155\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":57,"alternative-id":["S1463423625000155"],"URL":"https:\/\/doi.org\/10.1017\/s1463423625000155","relation":{},"ISSN":["1463-4236","1477-1128"],"issn-type":[{"value":"1463-4236","type":"print"},{"value":"1477-1128","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"\u00a9 The Author(s), 2025. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e26"}}